# A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

> clinical trial · VERIFIED · 2026-07-10

Status: NOT_YET_RECRUITING · Sponsor: BioLab Holdings · Condition: Undergone Mohs Micrographic Surgery

- Company: BioLab Holdings
- Sector: Undergone Mohs Micrographic Surgery
- Primary source: https://clinicaltrials.gov/study/NCT07695389

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.